fda compounding semaglutide news today 2025 September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines FDA Intensifies Crackdown on GLP-1

Phase 2 data showed participants losing up to 18.7% of body weight at the highest dose over 46 weeks

Chromatographic conditions included a column temperature of 30C, a mobile phase of 0.1% formic acid in water (A) and pure acetonitrile (B), and a sample injection volume of 2 L at an autosampler temperature of 4 C

This is boring, but so is explaining the cost of AI in healthcare to a board after preventable compliance debt explodes into legal spend

Researchers are responsible for compliance with Therapeutic Goods Administration (TGA) regulations and their institution's protocols

However, it still lacks long-term human clinical data on its efficacy and safety profile

IL-18 in patients with septic ARDS were significantly higher than patients with sepsis alone, demonstrating that IL-18 in sepsis are key cytokines causing lung injury (158)